Evaluation of napromustine, a nitrogen mustard derivative of naphthalimide, as a rationally designed mixed-function anticancer agent

Experimental Oncology

Volumn 24, Issue 3, 2002, Pages 173-179

  Pain, A ^a   Samanta, S ^a   Dutta, S ^a   Saxena, A K ^b   Shanmugave, M ^b   Kampasi, H ^b   Qazi, G N ^b   Sanyal, U ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Alkylating activity; Anticancer agent; Mustine derivative; Screening

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORMETHINE DERIVATIVE; CYCLOPHOSPHAMIDE; FLUOROURACIL; N DI(2 CHLOROETHYL)AMINE; NAPROMUSTINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; EHRLICH ASCITES TUMOR; EVALUATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; RNA SYNTHESIS; SARCOMA 180;

EID: 0036765518     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Tew KD, Colvin OM, Chabner BA. Alkylating agents. In: Cancer chemotherapy and biotherapy - principles and practice. Chabner BA, Longo DL, eds. Philadelphia: Lippincot Williams & Wilkins, 2001: 373 p. and the references cited therein.
2. Tercel M, Lee AE, Hogg A, Anderson RF, Lee HH, Siim BG, Denny WA, Wilson WR. Hypoxia-selective antitumor agents. 16. Nitroarylmethyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine. J Med Chem 2001; 44: 3511-22 and the references cited therein.
3. Brana MF, Sanz AM, Castellano JM, Roldan CM, Roldan C. Synthesis and cytostatic activity of benz(de)isoquinolin-1,3-diones. Structure activity relationships. Eur J Med Chem 1981; 16: 207-12.
4. Brana MF, Castellano JM, Roldan CM, Santos A, Vazquez D, Jimenez A. Synthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8-naphthalic acid. Cancer Chemother Pharmacol; 1980; 4: 61-6.
5. Rosell R, Carles J, Abad A, Ribelles N, Barnadas A, Benavides A, Martin M. Phase I study of Mitonafide in 120 hour continuous infusion in non-small cell lung cancer. Invest New Drugs 1992; 10: 171-5.
6. Samanta S, Pain A, Dutta S, Sanyal U. Evaluation of Napro-NU, a 2-chloroethylnitrosourea derivative of naphthalimide as a rationally designed mixed-function anti-cancer agent. Exp Oncol 2001; 23: 260-6.
7. Wade PC. Use of 2-(hydroxyalkyl)-1H-benz[de] isoquinoline-1,3(2H)-diones as antiallergy agents. US Patent 4,006,238 through Chem Abs 1977; 86: P145941t.
8. Quingchang M, Abdelmalik S, Sumanas R. Preparation of 5-alkoxytryptamine derivatives as migraine treating drugs. US Patent 5,654,431 through Chem Abs 1997; 127: P205473u.
9. Geran RI, Greenberg NH, MacDonald MM, Schumacher AM, Abbott BJ. Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother Rep 1972; 3: 1-103.
10. Mauck JC, Davis JE. Clinical Enzymology. In: Gradwohl's clinical laboratory methods and diagnosis. Sonnewirth AC, Jarett L, eds. St. Louis: CV Mosby, 1980: p. 305-23.
11. Panda CK, Chowdhury K, Sanyal U, Chakraborti SK. Mechanism of action of alpha-methylene-gamma-lactone derivatives of substituted nucleic acid bases in tumour cells. Chemotherapy 1989; 35: 174-80.
12. Dasgupta PS, Lahiri T. Antitumor effect of i.p. dopamine in mice bearing Ehrlich ascites carcinoma. J Cancer Res Clin Oncol 1987; 113: 363-8.
13. Skehan P, Storeng R, Scudiero D, Monks A, Mcmahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. New colorimetric cytotoxicity assay for anti-cancer drug screening. J Natl Cancer Inst 1990; 82: 1107-12.
14. Wheeler GP, Chumley S. Alkylating activity of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds. J Med Chem 1967; 10: 259-61.
15. Grochow LB. Covalent DNA-Binding Drugs. Cyclophosphamide. In: The chemotherapy source book. 2nd edition. Perry MC, ed. Baltimore: Williams & Wilkins, 1996: p.297-9.
16. Ghosh M, Sadhu U, Bhattacharya S, Dutta S, Bhattacharya B, Sanyal U. Evaluation of toxicity of β-tethymustine, a new anticancer compound, in mice. Cancer Lett 1999; 138: 107-14 and the references cited therein.